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Background & aims: To identify ID risk factors in infancy, and try to explore why ID is more prevalent in
boys than in girls in the ﬁrst year of life.
Methods: Amultiple logistic regressionwasperformedondata of 201 infants,with ferritin<12ng/ml as the
dependent variable and months of breastfeeding, weight gain from birth to 9 months (WG), and gender as
independent variables. To compare haematological parameters we used ManneWhitney and t test.
Results: From the 39 infants with IDA (19.4%), 24 (61.5%) were male and of the 162 infants without IDA,
50% were male (p ¼ 0.195). The median(minimum; maximum) ferritin concentrations in male infants at 9
months was of 9.8 ng/ml (0.5e67.0 ng/ml) and in females 14 ng/ml (0.5e74.5 ng/ml), p < 0.001. The
average (SD) WG was of 5863.3 g (855.4 g) in male infants and 5556.9 g (1054.3 g) in female infants
(p ¼ 0.027).
A multiple logistic regression (OR; 95%CI) showed that male gender was the most important risk factor
(OR: 3.3; 1.7e6.3; p < 0.001), followed by a higher weight increase (OR: 1.6; CI [1.1; 2.2]; p ¼ 0.016) and
longer breastfeeding time (OR: 1.1; CI [0.98; 1.2]; p ¼ 0.099).
Comparison of other haematological parameters at 9 months in relation to gender (males (M): 105;
females (F): 96) showed signiﬁcant differences in: mean  SD, Mean Corpuscular Haemoglobin (M:
25.0  2.1; F: 25.8  2.4 pg, p ¼ 0.001), Mean Corpuscular Volume (M: 73.4  4.1; F: 75.3  4.2 ﬂ, 0.009),
RDW (M: 14.6  1.5; F: 14.1  1.6%, p ¼ 0.048), Plaquelets (M: 324.9  77.9; F: 350.5  81.4  103/ml,
p ¼ 0.026).
Conclusions: ID was signiﬁcantly more frequent in male infants, independent of rapid growth or longer
breastfeeding duration.
The clinical risk proﬁle for ID in infants includes male gender and not only rapid growth, and longer
breastfeeding duration.
 2012 Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism.
1. Introduction
Iron requirements in humans vary according to age and gender.1
The iron deﬁcient anaemia (IDA) criteria depend on the following
factors: age, gender, altitude, and eventual pregnancy.2 At present,
the consensus is to separate the IDA criteria by gender starting only
at puberty.3 Using the current deﬁnitions, there is a male
predominance in infants with IDA and therefore, it should be asked
whether the IDA deﬁnition in infants should be differentiated by
gender at an earlier age.4 In fact, if in puberty the endocrine
changes provide an explanation for different IDA criteria, there is no
clear reason for this incongruity in infancy. Domellof et al. proposed
to change the IDA criteria in infants by gender.4 However, it can be
argued that it is not the criteria that should be changed but the iron
requirements in the ﬁrst year of life.5 Actually, if there is a greater
body weight increase in male infants in the ﬁrst year of life and if
male infants have more lean body mass than girls,6 these factors
could explain the ID predominance in male infants.5
Lozoff et al. tried to ﬁnd variables associated with ID and re-
ported that a greater rapid growth was associated with an
increased incidence of ID in infants.6
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In 2007, Wieringa et al., published a study using a large database
from four randomized controlled trials and showed that infant boys
had 3.3 times higher risk of suffering from ID than girls. Wieringa
et al. concluded that the iron requirements in ﬁrst year of life need
to be differentiated by gender, based on the response to iron
supplementation.7 Longer breastfeeding period8,9 and faster
growth are positively correlated with ID risk.6
Genetic and/or hormonal factors may be responsible for weight
and lean body mass differences and perhaps these differences can
be related to either iron status or more probably increased iron
requirements in the ﬁrst year of life in males.
Is faster growth inmales the only reason for the reported gender
differentiation pertaining to ID in infants, or are there other factors
also involved, namely different iron genetic proﬁle?
The aim of this study is to identify risk factors for ID in infancy,
and try to explore why ID is more prevalent in boys than in girls in
the ﬁrst year of life.
2. Participants and methods
All newborns from Braga Hospital (BH), a Portuguese University
and tertiary Hospital, born between 30 August and 3 October 1994
with the following criteria were included: healthy term newborn
with adequate weight for gestational age10 and being a single birth.
The entire group was observed at the age of nine months.
2.1. Protocol of the study at nine months
The protocol of the study included: mothers’ complete clinical
information (age, income, education, number of previous births,
and iron supplementation during pregnancy), the child e
newborn and infant e feeding (number of months of breastfeed-
ing, formula feeding, age at introduction of solid food), vaccination
(national programme or/and other vaccines not included in it),
supplements (vitamins or minerals), anthropometrical data
(weight, length, and head circumference at birth and at nine
months), and family social-economic and cultural information. The
same paediatrician assembled the protocol information through
hospital records, personal health registers, parents query and
physical examination.
Infants’ blood samples were taken for complete blood cell count
and for serum iron, transferrin, and ferritin. The blood samples
were collected in test tubes with EDTA (Niro-Neotube). All
samples were analysed between 30 min and 2 h after collection, in
the automatic counting blood cell system of Sysmex Toa-Medical
Electronics Co., Kobe. Smears were done in all who presented
anaemia or any other cellular indices alterations. Serum iron
concentration was measured by the “Ferrozyne” method (Hoffman
La Roche) and transferrin concentrations by the turbo-diametric
method (Dako, CobasMiras-Roche Diagnostics). Ferritin was
determined by the radio-immunoassay (Diagnostic Products Cor-
poration), the method of determination that has been considered
standard since 1985.11
2.2. IDA and ID deﬁnition
The IDA deﬁnition used was from the WHO: in 9 month old
infants haemoglobin (Hb) < 110 g/l,12 with low ferritin. The ID
deﬁnition used was ferritin < 12 ng/ml.12
2.3. Study design
This is an observational study with iron therapy in infants with
IDA according to WHO diagnostic criteria at 9 months of age.
Infants with IDA completed the treatment with oral iron
supplements, in the form of iron sulphate solution, 3 mg/kg/day,
twice daily and before meals.
All IDA infants needed to have treatment with oral iron
supplements for at least four months and to a maximum of six.
2.4. Statistical analysis
A multivariate analysis was applied with a cut off of 12 ng/ml of
ferritin as a dependent variable at 9 months. For independent
variables, we used breastfeeding duration, gender and weight gain
from birth to the age of nine months. To compare haematological
parameters we used ManneWhitney U and t test.
2.5. Ethics
Written consent was obtained from the children’s parents
involved in this research.
The Ethical Committee of SMH approved this study.
3. Results
From the newborns selected at birth, 54 were excluded for not
fulﬁlling the basal criteria: 35 being larger for their gestational age;
7 had intra-uterine growth retardation (IUGR); 8 were premature
and 4 were born from multiple births.
At 9months of age, 246 infants were called. From these,15 (6% of
the eligible sample) did not come to the appointment and 5 infants
were excluded for not meeting the inclusion criteria (3 were larger
for their gestational age, 1 IUGR and 1 premature) and, erroneously,
had been included in the sample.
From these 226, 25 infants did not complete the protocol (11%
was the total sample loss after observation). The parents of 23
infants refused the blood sample collection and in 2 the blood
sample was insufﬁcient. Hence, of the 246 newborns selected, 201
infants completed the entire protocol (83.4%).
There were no statistical differences between the mothers (age,
social environment, number of years of education, number of
previous births, and iron supplementation during pregnancy) and
newborns (weight, length, and head circumference at birth), in the
group studied and in the group excluded from analysis due to not
completing the protocol.
The Hb was less than 110 g/l in 83 (41.3%) out of 201 infants; the
prevalence of ID was 39.3% (79 infants) [95%CI, 32.5e46.2%].
Within infants with IDA, 17 (43.6%) had Hb concentrations
between 109 and 105 g/l; 14 (35.9%) between 104 and 100 g/l, and
the remaining 8 (20.5%) infants had Hb concentrations between 99
and 90 g/l. The lowest value of Hb found in this 9 month old pop-
ulation was 91 g/l. Of the infants with anaemia but without IDA,
34.0% had Hb of 109 g/l.
The prevalence of IDA was 19.4% (39 infants), [95%CI; 14.5e
25.4%].
All 39 infants with IDA initiated oral iron treatment, 3 mg/kg/
day, which theymaintained until Hb values as well as ferritin levels
had normalized. After 3 months of therapy, three of these infants
(7.7%) did not present Hb levels equal or superior to 110 g/l, but
there was a increase of the Hb > 10 g/l; 23 infants (59.0%) had
ferritin concentrations < 12 mg/l. At the sixth month mark of
therapy on oral iron, all 39 infants with IDA normalized both the Hb
and ferritin levels.
The average breastfeeding duration was 3 months (range: 0e9
months) in males and 3 months (1e9 months) in females
(p ¼ 0.737). The number of months on iron supplemented formula
was 4 months (0e9 months) in males and 4 months (0e9 months)
in females (p ¼ 0.732).
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The haematological parameters at 9 months by gender are
shown in Table 1.
Of the 39 infants suffering from IDA, 24 (61.5%) weremale and of
the 162 infants without IDA, 50% were male (p ¼ 0.195).
Ferritin concentrations were signiﬁcantly lower in male infants
than in female infants at 9 months of age. The median ferritin
concentration in male infants was of 9.8 ng/ml (range: 0.5e67.0 ng/
ml) and in females it was of 14.0 ng/ml (range 0.5e74.5 ng/ml),
p< 0.001. Of a total of 105 male infants, 55 had low ferritin levels at
nine months, and 24 out of the 96 female infants had low ferritin
levels (p < 0.001).
Twenty-four out of the 55 males fulﬁlled the criteria of IDA.
Fifteen out of the 24 females had IDA (p ¼ 0.195).
The mean (SD) weight gain between birth and nine months
was 5863.3 g (855.4 g) in male infants and 5556.9 g (1054.3 g) in
female infants (p ¼ 0.027).
In the multivariate analysis (Table 2) for weight, the risk for ID
increased 1.6 times for each 1 kg increase in weight (p ¼ 0.016).
Furthermore, every additional month of breastfeeding increased
the risk for ID 1.1 times (p ¼ 0.099). However, regardless of the
weight gain and breastfeeding duration, males had an increased
risk of 3.3 times of having ID in infancy than girls (p < 0.001)
showing that males are faced with an increased risk of having ID
after correcting for weight gain and breastfeeding duration.
4. Discussion
This study shows that male infants have an increased risk for ID,
which is not explained by differences in weight gain or breast-
feeding practices.
Why is there a higher prevalence of boys rather than girls
suffering from ID in the ﬁrst year of life? There are very few
previous studies addressing this question.4
The higher proportion of male children in studies on IDA in
infants4,5,13 is quite constant, with few exceptions.6 In our study,
ferritin concentrations in male infants were also signiﬁcantly lower
than in females at 9 months of age.
Sherriff et al.14 also found, in 1141 children studied in the United
Kingdom, that ferritin concentrations at twelve months were lower
in males. However, there is not a deﬁnite and consensual answer
among the scientiﬁc community that this predominance of males
with ID may be explained by physiological, genetic, and/or endo-
crine differences between the sexes. One explanation for the high
risk for ID in male infants could be the gain of more muscle mass in
boys or simply that the higher increase of body weight makes them
more vulnerable to ID.
In Wieringa et al.’s study in Southeast Asia, the risk of ID in boys
was 3.3 times higher than in girls.7 The study used four databases
including a large sample for an iron interventional study from three
different Southeast Asian countries.7 Although it was totally
different from ours, which used a small prospective Portuguese
sample of infants to study neurodevelopmental differences
between IDA and non-IDA infants,5 the results in both studies were
similar: higher risk for ID in male infants.
Domellof et al. proposed a deﬁnition of ID differences between
the sexes in the ﬁrst year of life due to male predominance of ID.4
This observation could be linked to the irons’ kinetics in the ﬁrst
year of life, or it could reﬂect the dietary inﬂuence and the probable
lean body mass increase, which is demonstrated in Motil et al.’s
chart15: a gain of 4.0 kg of lean mass in females during the ﬁrst year
versus 4.8 kg in males or merely a higher weight increment in boys,
knowing that weight gain implies more iron needs.6 Genetic factors
may also be responsible for explaining this increased ID risk proﬁle
but also could explain the weight gain and higher probability of
lean body mass.
Can the weight gain be the only reason for the increased prev-
alence of boys in studies on IDA in infancy? In our research, we
showed that there was a signiﬁcant weight gain difference when
comparing the two sexes, with males gaining more weight.5 As the
highest weight increment is associated with a higher iron
requirement, the risk of ID and IDA6,8,9 in boys could be naturally
justiﬁed. The largest weight increment and lean body mass differ-
ence between the sexes could be genetically determined, but the
ﬁnal result is a higher requirement for iron in the ﬁrst year of life in
males. However, although the weight gain increment was posi-
tively associated to ID risk, the multivariate analysis showed that
the male gender is more susceptible to ID, evenwhen correcting for
differences in weight gain. Hence, weight gain did not explain all
the increased risk for boys having ID in infancy.
In our study, being a male is a far greater risk factor for low
ferritin concentrations than rapid growth6 or longer breast
feeding.8,9
If the differences found were only the result of the kinetics of
iron in the ﬁrst year of life, and due to this, the deﬁnition of ID
should be modiﬁed in this age group, this would not explain why
these infants that were studied, predominantly males, had worse
results in the Grifﬁths test at twelve, ﬁfteen months and ﬁve years.5
The Grifﬁths test is a development test with a general coefﬁcient
and ﬁve sub-scales that measures the development of the child and
can be used until eight years of age.16 The existence of repercus-
sions in infants’ development sustains the hypothesis of functional
ID, and not that of a deﬁnition of ID or IDA by gender, in this age
group. Wieringa’s study conﬁrms the hypothesis because in iron
supplemented boys this difference between the levels of ferritin by
gender was not found; it only existed in non-supplemented
infants.7
Male gender is a clinical risk factor for ID in infants and it is well
known that IDA in infants is associated with development delay.5
Table 1
Haematological parameters at 9 months by gender.
At 9 months
Males (n ¼ 105) Females (n ¼ 96)
p*Mean SD Mean SD
Haemoglobin (g/l) 112.3 6.0 111.7 9.6 0.614
Haematocrit (%) 33.2 2.4 33.0 2.6 0.540
Mean corp. haemogl. (pg) 25.0 2.1 25.8 2.4 0.001
Mean corp. volume (ﬂ) 73.4 4.1 75.3 4.2 0.009
MCHC (g/dl) 34 31e36 34 31e36 0.064**
Platelets (103/ml) 324.9 77.9 350.5 81.4 0.026
RDW (%) 14.6 1.5 14.1 1.6 0.048
Leucocytes (103/ml) 9.08 2.60 9.38 3.2 0.208
Transferrin (mg/dl) 279.3 56.1 266.8 54.9 0.113
Ferritin (ng/ml) 9.8 0.5e67 14.0 0.5e74 <0.001**
Iron (ng/dl) 44.4 21.8 39.7 20.2 0.118
SD: standard-deviation. *test t. ** test ManneWhitney U.
m e minimum; M e maximum; MCHC: mean corpuscular haemoglobin
concentration.
Table 2
Multivariate analyses with ferritin at 9 months as dependent variable (less than
12 ng/ml) and independently variables: months of breastfeeding, weight gain from
birth to 9 months, in kg, and gender.
Risk of iron deﬁciency at nine months OR 95% CI p
Weight gain (in kg) 1.6 [1.1; 2.2] 0.016
Months of breastfeeding 1.1 [0.98; 1.2] 0.099
Gender
Female e
Male 3.3 [1.7; 6.3] <0.001
OR¼ odds ratio; CI¼ Conﬁdence interval; Iron deﬁciency¼ ferritin less than12ng/ml.
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The iron supplement is not innocuous and the blood test for IDA
in all infants is difﬁcult to obtain and a clinical risk proﬁle is needed.
As a clinical risk proﬁle we propose male gender, weight gain from
birth to six months and breastfeeding duration. In our study, at the
age of ninemonths, some of the infants were already suffering from
IDA or ID5 which implied development delay. Thus, perhaps that
risk proﬁle should be applied at the age of six months.
The iron requirements in the ﬁrst year of life must be revaluated
and perhaps altered according to gender, concluding that the
difference in body weight gain cannot explain all these differences
in gender.
Recently, a study tracked Hb from 6 months of life to 4 years old
and the results showed no inﬂuence of food except signiﬁcantly
high ferritin in boys who consumed meat.17 These results were in
line with ours and give more arguments to a genetic proﬁle.
There are ﬁve meta-analysis published in medline about oral
iron therapy before 18 years, but none only in infants or in devel-
oped countries.7,9,18e20
We invite other researchers to study ID in the ﬁrst year of life to
use their databases to contest or conﬁrm these results.
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